263 related articles for article (PubMed ID: 17264079)
1. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.
Murphy JW; Cho Y; Sachpatzidis A; Fan C; Hodsdon ME; Lolis E
J Biol Chem; 2007 Mar; 282(13):10018-10027. PubMed ID: 17264079
[TBL] [Abstract][Full Text] [Related]
2. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
Ziarek JJ; Veldkamp CT; Zhang F; Murray NJ; Kartz GA; Liang X; Su J; Baker JE; Linhardt RJ; Volkman BF
J Biol Chem; 2013 Jan; 288(1):737-46. PubMed ID: 23148226
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the stromal cell-derived factor-1alpha-heparin complex.
Sadir R; Baleux F; Grosdidier A; Imberty A; Lortat-Jacob H
J Biol Chem; 2001 Mar; 276(11):8288-96. PubMed ID: 11087743
[TBL] [Abstract][Full Text] [Related]
4. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.
Veldkamp CT; Peterson FC; Pelzek AJ; Volkman BF
Protein Sci; 2005 Apr; 14(4):1071-81. PubMed ID: 15741341
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine.
Amara A; Lorthioir O; Valenzuela A; Magerus A; Thelen M; Montes M; Virelizier JL; Delepierre M; Baleux F; Lortat-Jacob H; Arenzana-Seisdedos F
J Biol Chem; 1999 Aug; 274(34):23916-25. PubMed ID: 10446158
[TBL] [Abstract][Full Text] [Related]
6. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
Gozansky EK; Louis JM; Caffrey M; Clore GM
J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
[TBL] [Abstract][Full Text] [Related]
8. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).
Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF
J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153
[TBL] [Abstract][Full Text] [Related]
9. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.
Hecht I; Hershkoviz R; Shivtiel S; Lapidot T; Cohen IR; Lider O; Cahalon L
J Leukoc Biol; 2004 Jun; 75(6):1139-46. PubMed ID: 15020655
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10).
Campanella GS; Lee EM; Sun J; Luster AD
J Biol Chem; 2003 May; 278(19):17066-74. PubMed ID: 12571234
[TBL] [Abstract][Full Text] [Related]
11. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.
Valenzuela-Fernández A; Palanche T; Amara A; Magerus A; Altmeyer R; Delaunay T; Virelizier JL; Baleux F; Galzi JL; Arenzana-Seisdedos F
J Biol Chem; 2001 Jul; 276(28):26550-8. PubMed ID: 11352904
[TBL] [Abstract][Full Text] [Related]
12. Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha.
Mbemba E; Gluckman JC; Gattegno L
Glycobiology; 2000 Jan; 10(1):21-9. PubMed ID: 10570220
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
[TBL] [Abstract][Full Text] [Related]
15. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
Tanegashima K; Tsuji K; Suzuki K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Nov; 587(23):3770-5. PubMed ID: 24161674
[TBL] [Abstract][Full Text] [Related]
16. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
17. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
[TBL] [Abstract][Full Text] [Related]
18. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.
Loetscher P; Gong JH; Dewald B; Baggiolini M; Clark-Lewis I
J Biol Chem; 1998 Aug; 273(35):22279-83. PubMed ID: 9712844
[TBL] [Abstract][Full Text] [Related]
19. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
